Haloperidol Tablet
Product Images NDC 55154-5059

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 55154-5059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)
Chemical structure of haloperidol depicting its molecular components and arrangement as submitted in the product labeling.*
FDA Label Image

5mg Bag Label (3dd4fea4 D455 5a4d E063 6394a90ab14c 00)

5mg Bag Label (3dd4fea4 D455 5a4d E063 6394a90ab14c 00)
Haloperidol tablets USP 5 mg label for a 10-tablet package. The orange, round tablets are debossed with 'MYLAN 327'. The label includes dosage form (oral tablet), manufacturer information (Mylan Pharmaceuticals, made in India), and distributor details (Cardinal Health). Storage and warning information is also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.